Bio Green Med Solution (BGMS) Interest & Investment Income (2010 - 2024)
Bio Green Med Solution (BGMS) posted quarterly Interest & Investment Income of $2000.0 for Q1 2024, down 98.28% year-over-year from $116000.0 in Q2 2023, and down 91.3% quarter-over-quarter from $23000.0 in Q4 2023.
Analysis
Bio Green Med Solution (BGMS) Interest & Investment Income (2010 - 2024) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Interest & Investment Income for 15 consecutive years, with $2000.0 the latest figure, recorded in Q1 2024.
- In Q1 2024, Interest & Investment Income fell 98.28% year-over-year to $2000.0; the TTM figure through Mar 2024 stood at $152000.0 (down 52.8% YoY), while the FY2024 annual figure was $12000.0, down 95.49% from the prior year.
- Interest & Investment Income fell to $2000.0 in Q1 2024 per BGMS's latest filing, from $23000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $122000.0 in Q4 2022 and bottomed at $2000.0 in Q1 2024.
- Historically, Interest & Investment Income has averaged $31529.4 across 5 years, with a median of $6000.0 in 2020.
- Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 2950.0% — and 2024, when it sank 98.28%.
- Bio Green Med Solution's Interest & Investment Income stood at $6000.0 in 2020, then plunged by 33.33% to $4000.0 in 2021, then surged by 2950.0% to $122000.0 in 2022, then slumped by 81.15% to $23000.0 in 2023, then slumped by 91.3% to $2000.0 in 2024.
- Business Quant data shows BGMS's Interest & Investment Income at $2000.0 in Q1 2024, $23000.0 in Q4 2023, and $50000.0 in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Jun 30, 2023 | 77,000.00 |
| Mar 31, 2023 | 116,000.00 |
| Dec 31, 2022 | 122,000.00 |
| Sep 30, 2022 | 67,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 4,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Mar 31, 2020 | 28,000.00 |
| Dec 31, 2019 | 47,000.00 |
| Sep 30, 2019 | 42,000.00 |
| Jun 30, 2019 | 56,000.00 |